Sweden
# |
Name |
Net Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 237.77 M
|
Dec. 31, 2023 | USD 29.22 | -3.00% |
|
Sweden |
|
2 |
USD 44.91 M
|
Dec. 31, 2023 | USD 8.44 | 1.06% |
|
Sweden |
|
3 |
USD 44.82 M
|
Dec. 31, 2024 | USD 3.53 | -1.01% |
|
Sweden |
|
4 |
USD 42.58 M
|
Dec. 31, 2023 | USD 52.33 | -2.11% |
|
Sweden |
|
5 |
USD 37.11 M
|
Dec. 31, 2023 | USD 4.60 | 0.04% |
|
Sweden |
|
6 |
USD 22.63 M
|
Dec. 31, 2023 | USD 18.98 | -4.07% |
|
Sweden |
|
7 |
USD 19.43 M
|
Dec. 31, 2023 | USD 18.49 | 0.08% |
|
Sweden |
|
8 |
USD 18.75 M
|
Dec. 31, 2023 | USD 13.28 | -2.29% |
|
Sweden |
|
9 |
USD 17.37 M
|
Dec. 31, 2023 | USD 3.19 | -1.80% |
|
Sweden |
|
10 |
USD 15.50 M
|
Dec. 31, 2024 | USD 41.47 | -0.80% |
|
Sweden |
|
11 |
USD 12.86 M
|
Dec. 31, 2023 | USD 19.20 | -5.48% |
|
Sweden |
|
12 |
USD 10.86 M
|
Dec. 31, 2023 | USD 3.55 | -2.70% |
|
Sweden |
|
13 |
USD 10.22 M
|
Dec. 31, 2023 | USD 0.21 | -4.72% |
|
Sweden |
|
14 |
USD 6.07 M
|
Dec. 31, 2023 | USD 2.25 | -17.68% |
|
Sweden |
|
15 |
USD 4.55 M
|
Dec. 31, 2023 | USD 3.64 | -2.31% |
|
Sweden |
|
16 |
USD 3.74 M
|
Dec. 31, 2023 | USD 2.53 | -0.42% |
|
Sweden |
|
17 |
USD 2.63 M
|
Dec. 31, 2023 | USD 20.58 | -5.59% |
|
Sweden |
|
18 |
USD 2.47 M
|
Dec. 31, 2023 | USD 0.79 | -7.19% |
|
Sweden |
|
19 |
USD 1.20 M
|
Dec. 31, 2023 | USD 2.77 | -4.78% |
|
Sweden |
|
20 |
USD 20.92 K
|
Dec. 31, 2023 | USD 0.22 | -4.95% |
|
Sweden |
|
21 |
USD -43.23 K
|
Dec. 31, 2023 | USD 0.14 | 2.05% |
|
Sweden |
|
22 |
USD -178.55 K
|
Dec. 31, 2023 | USD 0.81 | -4.47% |
|
Sweden |
|
23 |
USD -980.09 K
|
Dec. 31, 2023 | USD 0.38 | -3.14% |
|
Sweden |
|
24 |
USD -1.09 M
|
Dec. 31, 2023 | USD 0.27 | -2.38% |
|
Sweden |
|
25 |
USD -1.33 M
|
April 30, 2024 | USD 0.13 | -1.11% |
|
Sweden |
|
26 |
USD -1.57 M
|
Dec. 31, 2023 | USD 0.47 | -2.96% |
|
Sweden |
|
27 |
USD -1.62 M
|
Dec. 31, 2023 | USD 0.31 | 1.24% |
|
Sweden |
|
28 |
USD -1.63 M
|
Dec. 31, 2023 | USD 0.25 | -3.82% |
|
Sweden |
|
29 |
USD -1.69 M
|
Dec. 31, 2023 | USD 0.84 | -2.95% |
|
Sweden |
|
30 |
USD -1.77 M
|
Dec. 31, 2023 | USD 0.12 | -1.48% |
|
Sweden |
|
31 |
USD -1.80 M
|
Dec. 31, 2023 | USD 0.16 | -2.74% |
|
Sweden |
|
32 |
USD -2.02 M
|
Dec. 31, 2023 | USD 0.18 | -3.03% |
|
Sweden |
|
33 |
USD -2.08 M
|
Dec. 31, 2023 | USD 0.09 | -2.04% |
|
Sweden |
|
34 |
USD -2.08 M
|
Dec. 31, 2023 | USD 0.85 | -1.32% |
|
Sweden |
|
35 |
USD -3.52 M
|
Dec. 31, 2023 | USD 0.21 | 1.47% |
|
Sweden |
|
36 |
USD -3.67 M
|
Dec. 31, 2023 | USD 0.12 | -10.10% |
|
Sweden |
|
37 |
USD -3.67 M
|
Dec. 31, 2023 | USD 1.25 | -0.41% |
|
Sweden |
|
38 |
USD -4.07 M
|
Aug. 31, 2024 | USD 0.26 | 0.92% |
|
Sweden |
|
39 |
USD -4.53 M
|
Dec. 31, 2023 | USD 0.39 | -4.99% |
|
Sweden |
|
40 |
USD -4.91 M
|
Dec. 31, 2023 | USD 0.13 | 0.88% |
|
Sweden |
|
41 |
USD -5.88 M
|
Dec. 31, 2023 | USD 1.59 | -2.74% |
|
Sweden |
|
42 |
USD -6.40 M
|
Dec. 31, 2023 | USD 0.09 | -2.98% |
|
Sweden |
|
43 |
USD -7.42 M
|
Dec. 31, 2023 | USD 0.19 | -8.49% |
|
Sweden |
|
44 |
USD -10.03 M
|
Dec. 31, 2023 | USD 0.71 | 8.98% |
|
Sweden |
|
45 |
USD -10.15 M
|
Dec. 31, 2023 | USD 0.09 | 11.18% |
|
Sweden |
|
46 |
USD -10.79 M
|
Dec. 31, 2023 | USD 0.26 | -2.13% |
|
Sweden |
|
47 |
USD -11.18 M
|
Dec. 31, 2023 | USD 2.47 | -3.20% |
|
Sweden |
|
48 |
USD -11.30 M
|
April 30, 2024 | USD 0.18 | -8.41% |
|
Sweden |
|
49 |
USD -12.66 M
|
Dec. 31, 2023 | USD 1.64 | -3.31% |
|
Sweden |
|
50 |
USD -13.24 M
|
Dec. 31, 2023 | USD 0.50 | -2.16% |
|
Sweden |
The Healthcare company in Sweden with the highest Net Income is Swedish Orphan Biovitrum AB (publ) (Stockholm Stock Exchange: SOBI.ST) at USD 237.77 M.
The Healthcare company in Sweden with the lowest Net Income is Vitrolife AB (publ) (Stockholm Stock Exchange: VITR.ST) at USD -380.09 M.
The top 10 Healthcare companies in Sweden by Net Income are Swedish Orphan Biovitrum AB (publ), Ambea AB (publ), Arjo AB (publ), Camurus AB (publ), Attendo AB (publ), BioArctic AB (publ), Medicover AB (publ), AddLife AB (publ), Humana AB (publ) and Xvivo Perfusion AB (publ).
The bottom 10 Healthcare companies in Sweden by Net Income are Vitrolife AB (publ), Hansa Biopharma AB (publ), BioInvent International AB (publ), Egetis Therapeutics AB (publ), Vicore Pharma Holding AB (publ), Cantargia AB (publ), Oncopeptides AB (publ), SynAct Pharma AB, Xspray Pharma AB (publ) and IRLAB Therapeutics AB (publ).